Vertex Pharmaceuticals
(NASDAQ:VRTX)
292.55
9.05[3.19%]
At close: Jun 24
292.55
00
After Hours: 5:17PM EDT
Day High/Low280.28 - 293.17
52 Week High/Low176.36 - 293.17
Open / Close286.26 / 292.55
Float / Outstanding255.4M / 255.8M
Vol / Avg.4.3M / 1.8M
Mkt Cap74.8B
P/E30.86
50d Avg. Price264.95
Div / Yield-
Payout Ratio-
EPS2.99
Total Float255.4M

Vertex Pharmaceuticals (NASDAQ:VRTX), Quotes and News Summary

Vertex Pharmaceuticals (NASDAQ: VRTX)

Day High/Low280.28 - 293.17
52 Week High/Low176.36 - 293.17
Open / Close286.26 / 292.55
Float / Outstanding255.4M / 255.8M
Vol / Avg.4.3M / 1.8M
Mkt Cap74.8B
P/E30.86
50d Avg. Price264.95
Div / Yield-
Payout Ratio-
EPS2.99
Total Float255.4M
load more
Sector: Health Care.Industry: Biotechnology
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-07-28
REV
Q1 2022Est.ActualSurprise
EPS3.4903.520 0.0300
REV2.080B2.097B17.000M

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Vertex Pharmaceuticals Questions & Answers

Q
How do I buy Vertex Pharmaceuticals (VRTX) stock?
A

You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Vertex Pharmaceuticals's (VRTX) competitors?
Q
What is the target price for Vertex Pharmaceuticals (VRTX) stock?
A

The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Argus Research on Monday, June 13, 2022. The analyst firm set a price target for 280.00 expecting VRTX to fall to within 12 months (a possible -4.29% downside). 23 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Vertex Pharmaceuticals (VRTX)?
A

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $292.55 last updated June 24, 2022, 8:00 PM UTC.

Q
Does Vertex Pharmaceuticals (VRTX) pay a dividend?
A

There are no upcoming dividends for Vertex Pharmaceuticals.

Q
When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?
A

Vertex Pharmaceuticals’s Q2 earnings are confirmed for Thursday, July 28, 2022.

Q
Is Vertex Pharmaceuticals (VRTX) going to split?
A

There is no upcoming split for Vertex Pharmaceuticals.

Q
What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?
A

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.